DiaMedica Therapeutics (DMAC) EBT (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly EBT came in at -$10.0 million in Q1 2026, down 30.31% year-on-year from -$14.4 million in Q1 2025, and down 14.95% quarter-over-quarter from -$8.7 million in Q4 2025.
DiaMedica Therapeutics (DMAC) EBT (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' EBT history runs 9 years deep, the most recent figure standing at -$10.0 million for Q1 2026.
- On a quarterly basis, EBT fell 30.31% year-over-year to -$10.0 million in Q1 2026; TTM through Mar 2026 was -$35.1 million, a 30.04% decrease from a year earlier, with the FY2025 full-year figure at -$32.7 million, down 34.1% from the prior year.
- EBT retreated to -$10.0 million in Q1 2026 per DMAC's latest filing, from -$8.7 million in the prior quarter.
- Across five years, EBT topped out at -$3.1 million in Q3 2022 and bottomed at -$10.0 million in Q1 2026.
- The 5-year median for EBT is -$5.1 million (2024), against an average of -$5.9 million.
- Across the five-year window, EBT gained 11.36% in 2022 and plunged 53.55% in 2024, its largest moves.
- Year by year, EBT stood at -$3.7 million in 2022, then plunged by 37.26% to -$5.1 million in 2023, then plunged by 53.55% to -$7.9 million in 2024, then slipped by 10.63% to -$8.7 million in 2025, then declined by 14.95% to -$10.0 million in 2026.
- Per Business Quant, the three latest DMAC EBT figures stand at -$10.0 million (Q1 2026), -$8.7 million (Q4 2025), and -$8.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - | -10.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.04 Mn |
| Dec 31, 2025 | -8.73 Mn |
| Sep 30, 2025 | -8.61 Mn |
| Jun 30, 2025 | -7.69 Mn |
| Mar 31, 2025 | -7.70 Mn |
| Dec 31, 2024 | -7.89 Mn |
| Sep 30, 2024 | -6.27 Mn |
| Jun 30, 2024 | -5.11 Mn |
| Mar 31, 2024 | -5.14 Mn |
| Dec 31, 2023 | -5.14 Mn |
| Sep 30, 2023 | -4.46 Mn |
| Jun 30, 2023 | -4.47 Mn |
| Mar 31, 2023 | -5.27 Mn |
| Dec 31, 2022 | -3.74 Mn |
| Sep 30, 2022 | -3.05 Mn |
| Jun 30, 2022 | -3.35 Mn |
| Mar 31, 2022 | -3.50 Mn |
| Dec 31, 2021 | -3.24 Mn |
| Sep 30, 2021 | -3.44 Mn |
| Jun 30, 2021 | -3.27 Mn |